nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Ascites—Dactinomycin—melanoma	0.0423	0.0423	CcSEcCtD
Entecavir—Transaminases increased—Carmustine—melanoma	0.0296	0.0296	CcSEcCtD
Entecavir—Hepatomegaly—Dactinomycin—melanoma	0.0272	0.0272	CcSEcCtD
Entecavir—Ascites—Docetaxel—melanoma	0.0254	0.0254	CcSEcCtD
Entecavir—Oedema peripheral—Vemurafenib—melanoma	0.0168	0.0168	CcSEcCtD
Entecavir—Hepatic failure—Dactinomycin—melanoma	0.0155	0.0155	CcSEcCtD
Entecavir—Alopecia—Vemurafenib—melanoma	0.0151	0.0151	CcSEcCtD
Entecavir—Malnutrition—Vemurafenib—melanoma	0.0149	0.0149	CcSEcCtD
Entecavir—Hepatic failure—Temozolomide—melanoma	0.014	0.014	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.0126	0.0126	CcSEcCtD
Entecavir—Anaphylactic shock—Vemurafenib—melanoma	0.0121	0.0121	CcSEcCtD
Entecavir—Infection—Vemurafenib—melanoma	0.0121	0.0121	CcSEcCtD
Entecavir—Nervous system disorder—Vemurafenib—melanoma	0.0119	0.0119	CcSEcCtD
Entecavir—Skin disorder—Vemurafenib—melanoma	0.0118	0.0118	CcSEcCtD
Entecavir—Neutropenia—Dactinomycin—melanoma	0.0113	0.0113	CcSEcCtD
Entecavir—Haematuria—Bleomycin—melanoma	0.011	0.011	CcSEcCtD
Entecavir—Neutropenia—Carmustine—melanoma	0.0106	0.0106	CcSEcCtD
Entecavir—Gastrointestinal disorder—Vemurafenib—melanoma	0.0105	0.0105	CcSEcCtD
Entecavir—Fatigue—Vemurafenib—melanoma	0.0105	0.0105	CcSEcCtD
Entecavir—Neutropenia—Temozolomide—melanoma	0.0102	0.0102	CcSEcCtD
Entecavir—Hyperglycaemia—Carmustine—melanoma	0.0102	0.0102	CcSEcCtD
Entecavir—Upper respiratory tract infection—Temozolomide—melanoma	0.0101	0.0101	CcSEcCtD
Entecavir—Renal failure—Carmustine—melanoma	0.00989	0.00989	CcSEcCtD
Entecavir—Hyperglycaemia—Temozolomide—melanoma	0.00984	0.00984	CcSEcCtD
Entecavir—Hepatitis—Dactinomycin—melanoma	0.00965	0.00965	CcSEcCtD
Entecavir—Body temperature increased—Vemurafenib—melanoma	0.00959	0.00959	CcSEcCtD
Entecavir—Hepatic failure—Docetaxel—melanoma	0.00934	0.00934	CcSEcCtD
Entecavir—Hepatobiliary disease—Temozolomide—melanoma	0.0092	0.0092	CcSEcCtD
Entecavir—Alopecia—Bleomycin—melanoma	0.00914	0.00914	CcSEcCtD
Entecavir—Oedema peripheral—Carmustine—melanoma	0.0089	0.0089	CcSEcCtD
Entecavir—Hepatitis—Temozolomide—melanoma	0.00873	0.00873	CcSEcCtD
Entecavir—Asthenia—Vemurafenib—melanoma	0.00871	0.00871	CcSEcCtD
Entecavir—Oedema peripheral—Temozolomide—melanoma	0.0086	0.0086	CcSEcCtD
Entecavir—Alopecia—Dactinomycin—melanoma	0.00853	0.00853	CcSEcCtD
Entecavir—Diarrhoea—Vemurafenib—melanoma	0.0083	0.0083	CcSEcCtD
Entecavir—Leukopenia—Bleomycin—melanoma	0.00806	0.00806	CcSEcCtD
Entecavir—Dizziness—Vemurafenib—melanoma	0.00802	0.00802	CcSEcCtD
Entecavir—Alopecia—Carmustine—melanoma	0.00798	0.00798	CcSEcCtD
Entecavir—Mental disorder—Carmustine—melanoma	0.00791	0.00791	CcSEcCtD
Entecavir—Immune system disorder—Temozolomide—melanoma	0.00788	0.00788	CcSEcCtD
Entecavir—Malnutrition—Carmustine—melanoma	0.00786	0.00786	CcSEcCtD
Entecavir—Vomiting—Vemurafenib—melanoma	0.00772	0.00772	CcSEcCtD
Entecavir—Alopecia—Temozolomide—melanoma	0.00771	0.00771	CcSEcCtD
Entecavir—Abdominal pain upper—Docetaxel—melanoma	0.00766	0.00766	CcSEcCtD
Entecavir—Rash—Vemurafenib—melanoma	0.00765	0.00765	CcSEcCtD
Entecavir—Mental disorder—Temozolomide—melanoma	0.00765	0.00765	CcSEcCtD
Entecavir—Dermatitis—Vemurafenib—melanoma	0.00764	0.00764	CcSEcCtD
Entecavir—Headache—Vemurafenib—melanoma	0.0076	0.0076	CcSEcCtD
Entecavir—Malnutrition—Temozolomide—melanoma	0.0076	0.0076	CcSEcCtD
Entecavir—Leukopenia—Dactinomycin—melanoma	0.00752	0.00752	CcSEcCtD
Entecavir—Anaphylactic shock—Bleomycin—melanoma	0.00735	0.00735	CcSEcCtD
Entecavir—Infection—Bleomycin—melanoma	0.0073	0.0073	CcSEcCtD
Entecavir—Nausea—Vemurafenib—melanoma	0.00721	0.00721	CcSEcCtD
Entecavir—Leukopenia—Carmustine—melanoma	0.00704	0.00704	CcSEcCtD
Entecavir—Infection—Dactinomycin—melanoma	0.00681	0.00681	CcSEcCtD
Entecavir—Leukopenia—Temozolomide—melanoma	0.0068	0.0068	CcSEcCtD
Entecavir—Neutropenia—Docetaxel—melanoma	0.00678	0.00678	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00642	0.00642	CcSEcCtD
Entecavir—Infection—Carmustine—melanoma	0.00638	0.00638	CcSEcCtD
Entecavir—Renal failure—Docetaxel—melanoma	0.00636	0.00636	CcSEcCtD
Entecavir—Anaphylactic shock—Temozolomide—melanoma	0.0062	0.0062	CcSEcCtD
Entecavir—Infection—Temozolomide—melanoma	0.00616	0.00616	CcSEcCtD
Entecavir—Hepatobiliary disease—Docetaxel—melanoma	0.00612	0.00612	CcSEcCtD
Entecavir—Nervous system disorder—Temozolomide—melanoma	0.00608	0.00608	CcSEcCtD
Entecavir—Skin disorder—Temozolomide—melanoma	0.00602	0.00602	CcSEcCtD
Entecavir—Fatigue—Dactinomycin—melanoma	0.00591	0.00591	CcSEcCtD
Entecavir—Body temperature increased—Bleomycin—melanoma	0.00581	0.00581	CcSEcCtD
Entecavir—Hepatitis—Docetaxel—melanoma	0.0058	0.0058	CcSEcCtD
Entecavir—Insomnia—Carmustine—melanoma	0.0058	0.0058	CcSEcCtD
Entecavir—Oedema peripheral—Docetaxel—melanoma	0.00572	0.00572	CcSEcCtD
Entecavir—Somnolence—Carmustine—melanoma	0.0057	0.0057	CcSEcCtD
Entecavir—Insomnia—Temozolomide—melanoma	0.00561	0.00561	CcSEcCtD
Entecavir—Gastrointestinal pain—Dactinomycin—melanoma	0.00561	0.00561	CcSEcCtD
Entecavir—Gastrointestinal disorder—Carmustine—melanoma	0.00554	0.00554	CcSEcCtD
Entecavir—Somnolence—Temozolomide—melanoma	0.00551	0.00551	CcSEcCtD
Entecavir—Dyspepsia—Temozolomide—melanoma	0.00546	0.00546	CcSEcCtD
Entecavir—Abdominal pain—Dactinomycin—melanoma	0.00542	0.00542	CcSEcCtD
Entecavir—Body temperature increased—Dactinomycin—melanoma	0.00542	0.00542	CcSEcCtD
Entecavir—Gastrointestinal disorder—Temozolomide—melanoma	0.00535	0.00535	CcSEcCtD
Entecavir—Fatigue—Temozolomide—melanoma	0.00535	0.00535	CcSEcCtD
Entecavir—Asthenia—Bleomycin—melanoma	0.00527	0.00527	CcSEcCtD
Entecavir—Gastrointestinal pain—Carmustine—melanoma	0.00525	0.00525	CcSEcCtD
Entecavir—Immune system disorder—Docetaxel—melanoma	0.00524	0.00524	CcSEcCtD
Entecavir—Alopecia—Docetaxel—melanoma	0.00513	0.00513	CcSEcCtD
Entecavir—Mental disorder—Docetaxel—melanoma	0.00509	0.00509	CcSEcCtD
Entecavir—Abdominal pain—Carmustine—melanoma	0.00507	0.00507	CcSEcCtD
Entecavir—Body temperature increased—Carmustine—melanoma	0.00507	0.00507	CcSEcCtD
Entecavir—Gastrointestinal pain—Temozolomide—melanoma	0.00507	0.00507	CcSEcCtD
Entecavir—Malnutrition—Docetaxel—melanoma	0.00505	0.00505	CcSEcCtD
Entecavir—Asthenia—Dactinomycin—melanoma	0.00492	0.00492	CcSEcCtD
Entecavir—Abdominal pain—Temozolomide—melanoma	0.0049	0.0049	CcSEcCtD
Entecavir—Body temperature increased—Temozolomide—melanoma	0.0049	0.0049	CcSEcCtD
Entecavir—Diarrhoea—Dactinomycin—melanoma	0.00469	0.00469	CcSEcCtD
Entecavir—Vomiting—Bleomycin—melanoma	0.00467	0.00467	CcSEcCtD
Entecavir—Rash—Bleomycin—melanoma	0.00464	0.00464	CcSEcCtD
Entecavir—Dermatitis—Bleomycin—melanoma	0.00463	0.00463	CcSEcCtD
Entecavir—Asthenia—Carmustine—melanoma	0.0046	0.0046	CcSEcCtD
Entecavir—Leukopenia—Docetaxel—melanoma	0.00452	0.00452	CcSEcCtD
Entecavir—Asthenia—Temozolomide—melanoma	0.00445	0.00445	CcSEcCtD
Entecavir—Diarrhoea—Carmustine—melanoma	0.00439	0.00439	CcSEcCtD
Entecavir—Nausea—Bleomycin—melanoma	0.00437	0.00437	CcSEcCtD
Entecavir—Vomiting—Dactinomycin—melanoma	0.00436	0.00436	CcSEcCtD
Entecavir—Rash—Dactinomycin—melanoma	0.00432	0.00432	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00427	0.00427	CcSEcCtD
Entecavir—Dizziness—Carmustine—melanoma	0.00424	0.00424	CcSEcCtD
Entecavir—Diarrhoea—Temozolomide—melanoma	0.00424	0.00424	CcSEcCtD
Entecavir—Anaphylactic shock—Docetaxel—melanoma	0.00412	0.00412	CcSEcCtD
Entecavir—Dizziness—Temozolomide—melanoma	0.0041	0.0041	CcSEcCtD
Entecavir—Infection—Docetaxel—melanoma	0.0041	0.0041	CcSEcCtD
Entecavir—Vomiting—Carmustine—melanoma	0.00408	0.00408	CcSEcCtD
Entecavir—Nausea—Dactinomycin—melanoma	0.00407	0.00407	CcSEcCtD
Entecavir—Rash—Carmustine—melanoma	0.00405	0.00405	CcSEcCtD
Entecavir—Nervous system disorder—Docetaxel—melanoma	0.00404	0.00404	CcSEcCtD
Entecavir—Dermatitis—Carmustine—melanoma	0.00404	0.00404	CcSEcCtD
Entecavir—Headache—Carmustine—melanoma	0.00402	0.00402	CcSEcCtD
Entecavir—Skin disorder—Docetaxel—melanoma	0.00401	0.00401	CcSEcCtD
Entecavir—Vomiting—Temozolomide—melanoma	0.00394	0.00394	CcSEcCtD
Entecavir—Rash—Temozolomide—melanoma	0.00391	0.00391	CcSEcCtD
Entecavir—Dermatitis—Temozolomide—melanoma	0.00391	0.00391	CcSEcCtD
Entecavir—Headache—Temozolomide—melanoma	0.00388	0.00388	CcSEcCtD
Entecavir—Nausea—Carmustine—melanoma	0.00381	0.00381	CcSEcCtD
Entecavir—Insomnia—Docetaxel—melanoma	0.00373	0.00373	CcSEcCtD
Entecavir—Nausea—Temozolomide—melanoma	0.00368	0.00368	CcSEcCtD
Entecavir—Somnolence—Docetaxel—melanoma	0.00367	0.00367	CcSEcCtD
Entecavir—Dyspepsia—Docetaxel—melanoma	0.00363	0.00363	CcSEcCtD
Entecavir—Gastrointestinal disorder—Docetaxel—melanoma	0.00356	0.00356	CcSEcCtD
Entecavir—Fatigue—Docetaxel—melanoma	0.00356	0.00356	CcSEcCtD
Entecavir—Gastrointestinal pain—Docetaxel—melanoma	0.00337	0.00337	CcSEcCtD
Entecavir—Abdominal pain—Docetaxel—melanoma	0.00326	0.00326	CcSEcCtD
Entecavir—Body temperature increased—Docetaxel—melanoma	0.00326	0.00326	CcSEcCtD
Entecavir—Asthenia—Docetaxel—melanoma	0.00296	0.00296	CcSEcCtD
Entecavir—Diarrhoea—Docetaxel—melanoma	0.00282	0.00282	CcSEcCtD
Entecavir—Dizziness—Docetaxel—melanoma	0.00273	0.00273	CcSEcCtD
Entecavir—Vomiting—Docetaxel—melanoma	0.00262	0.00262	CcSEcCtD
Entecavir—Rash—Docetaxel—melanoma	0.0026	0.0026	CcSEcCtD
Entecavir—Dermatitis—Docetaxel—melanoma	0.0026	0.0026	CcSEcCtD
Entecavir—Headache—Docetaxel—melanoma	0.00258	0.00258	CcSEcCtD
Entecavir—Nausea—Docetaxel—melanoma	0.00245	0.00245	CcSEcCtD
